Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1986 1
1992 1
1994 1
1997 1
1998 2
2001 1
2003 1
2006 1
2008 1
2009 1
2010 1
2012 1
2020 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Estrogen and hypertension.
Ashraf MS, Vongpatanasin W. Ashraf MS, et al. Curr Hypertens Rep. 2006 Oct;8(5):368-76. doi: 10.1007/s11906-006-0080-1. Curr Hypertens Rep. 2006. PMID: 16965722 Review.
However, emerging evidence from recent clinical trials indicates a small increase, rather than decrease, in systolic BP with oral estrogen administration in postmenopausal women, without any detectable effect on diastolic BP. Mechanisms underlying this selective ris …
However, emerging evidence from recent clinical trials indicates a small increase, rather than decrease, in systolic BP with oral estrogen a …
Venous thromboembolism in women.
Rathbun S. Rathbun S. Vasc Med. 2008 Aug;13(3):255-66. doi: 10.1177/1358863X07085404. Vasc Med. 2008. PMID: 18687764 Review.
The risk of venous thromboembolism (VTE) varies throughout a woman's life and is associated primarily with underlying hormonal exposure. Alteration in hemostatic mechanisms, including resistance to activated protein C, may explain this altered risk. Initially, development …
The risk of venous thromboembolism (VTE) varies throughout a woman's life and is associated primarily with underlying hormonal exposu …
Intrauterine device practice guidelines: medical conditions.
Nelson AL. Nelson AL. Contraception. 1998 Sep;58(3 Suppl):59S-63S; quiz 72S. doi: 10.1016/s0010-7824(98)00084-5. Contraception. 1998. PMID: 9807694 Review.
Contraception selection poses special challenges to women with pre-existing medical problems and clinicians often lack the knowledge to counsel these women. ...Because IUDs have no direct systemic effects other than increasing circulating immunoglobulins and possibl …
Contraception selection poses special challenges to women with pre-existing medical problems and clinicians often lack the kno …
Contraception in women with intercurrent disease.
Vu KK, Zacur HA. Vu KK, et al. Curr Opin Obstet Gynecol. 1994 Dec;6(6):547-51. Curr Opin Obstet Gynecol. 1994. PMID: 7893962 Review.
The contraceptive chosen may adversely affect the underlying disease of the patient. Conversely, failure of contraception could result in pregnancy, which could also adversely affect the patient's underlying disease. These factors must be …
The contraceptive chosen may adversely affect the underlying disease of the patient. Conversely, failure of contrace …
Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion.
Dodson PM, Kritzinger EE. Dodson PM, et al. Trans Ophthalmol Soc U K (1962). 1985;104 ( Pt 2):114-9. Trans Ophthalmol Soc U K (1962). 1985. PMID: 3857768
Young patients had a highly significant decreased prevalence of hypertension compared to the older group (27 per cent versus 62 per cent: P less than 0.001), with hyperlipidaemia being the predominant underlying condition (35 per cent). Four young female patients presentin …
Young patients had a highly significant decreased prevalence of hypertension compared to the older group (27 per cent versus 62 per cent: P …
The pill and thrombosis: epidemiological considerations.
Carter C. Carter C. Baillieres Clin Obstet Gynaecol. 1997 Sep;11(3):565-85. doi: 10.1016/s0950-3552(97)80028-4. Baillieres Clin Obstet Gynaecol. 1997. PMID: 9488792 Review.
This places a greater emphasis on the selection of patients to help avoid giving medication to those patients with underlying thrombotic risk factors. ...The consensus of studies conducted up to 1995 was that there is a small but real increase in the incidence of de …
This places a greater emphasis on the selection of patients to help avoid giving medication to those patients with underlying …
Contraception in women with special medical needs.
Neinstein L. Neinstein L. Compr Ther. 1998 May;24(5):229-50. Compr Ther. 1998. PMID: 9626481 Review.
Over 10% of US women have experienced a serious chronic physical disorder or disease by the age of 18 years. Nonetheless, health professionals frequently are unprepared to counsel women with special medical problems about sexuality issues, including the potential adverse e …
Over 10% of US women have experienced a serious chronic physical disorder or disease by the age of 18 years. Nonetheless, health prof …
Sex-specific alterations in blood-borne factors in physically inactive individuals are detrimental to endothelial cell functions.
Sapp RM, Landers-Ramos RQ, Shill DD, Springer CB, Hagberg JM. Sapp RM, et al. J Appl Physiol (1985). 2020 Oct 1;129(4):664-674. doi: 10.1152/japplphysiol.00292.2020. Epub 2020 Jul 30. J Appl Physiol (1985). 2020. PMID: 32730175 Free PMC article.
Mechanisms underlying the protective effects of both habitual endurance exercise and the female sex on vascular function are incompletely understood. ...Real-time quantitative polymerase chain reaction was used to quantify an initial array of 84 cardiovascular di …
Mechanisms underlying the protective effects of both habitual endurance exercise and the female sex on vascular function are incomple …
Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
Goldzieher JW. Goldzieher JW. J Reprod Med. 1983 Jan;28(1 Suppl):53-6. J Reprod Med. 1983. PMID: 6403700
This article discusses some of the issues raised by development of a new low-dose oral contraceptive (OC) now available in the US after 12 years of clinical use around the world. ...Some controversy accompanies efforts to reduce grave adverse reactions to OCs, primarily …
This article discusses some of the issues raised by development of a new low-dose oral contraceptive (OC) now available in the US aft …
ACOG Practice Bulletin. The use of hormonal contraception in women with coexisting medical conditions. Number 18, July 2000.
ACOG Committee on Practice Bulletins-Gynecology. ACOG Committee on Practice Bulletins-Gynecology. Int J Gynaecol Obstet. 2001 Oct;75(1):93-106. doi: 10.1016/s0020-7292(01)00520-3. Int J Gynaecol Obstet. 2001. PMID: 11732484
Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data are far less complete for women with underlying medical problems or other special circumstances. Because recommendations vary widely, substanti …
Although numerous studies have addressed the safety and effectiveness of hormonal contraceptive use in healthy women, data are far le …
17 results